RNF213 regulates blood‒brain barrier integrity by targeting TRAF3 for type I interferon activation during A. baumannii infection.
RNF213 is the first identified susceptibility gene for moyamoya disease, and the encoded protein was recently recognized as a key antimicrobial protein. However, the function of RNF213 in host defense against brain infection remains unclear. Here, we show that increased expression of Rnf213 is signi...
Saved in:
| Main Authors: | Yanfeng Li, Qingqing Xie, Luyu Yang, Qian Jiang, Zhiping Liu, Chengjiang Gao, Xiaopeng Qi, Tao Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-07-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://doi.org/10.1371/journal.ppat.1013333 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peripheral blood GATA2 expression impacts RNF213 mutation penetrance and clinical severity in moyamoya disease
by: Ituro Inoue, et al. -
RNF213 Variant and Infectious Burden Associated With Intracranial Artery Stenosis in Moyamoya Disease
by: Chaofan Zeng, et al.
Published: (2025-03-01) -
RNF213 Acts as a Molecular Switch for Cav-1 Ubiquitination and Phosphorylation in Human Cells
by: Jungmi Choi, et al.
Published: (2025-05-01) -
Global research trends and emerging hotspots of RNF213 in Moyamoya disease: A bibliometric analysis (2011–2024)
by: Xiaozan Chang, et al.
Published: (2025-10-01) -
ATP functions as a pathogen-associated molecular pattern to activate the E3 ubiquitin ligase RNF213
by: Juraj Ahel, et al.
Published: (2025-05-01)